Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
23.04
-0.77 (-3.23%)
May 17, 2024, 4:00 PM EDT - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.08 billion as of May 17, 2024. Its market cap has increased by 38.06% in one year.
Market Cap
1.08B
Enterprise Value
763.64M
1-Year Change
38.06%
Ranking
Category
Stock Price
$23.04
Market Cap Chart
Since March 12, 2020, Enliven Therapeutics's market cap has increased from $244.90M to $1.08B, an increase of 342.71%. That is a compound annual growth rate of 42.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 1.08B | -3.23% |
May 16, 2024 | 1.12B | -0.80% |
May 15, 2024 | 1.13B | 0.54% |
May 14, 2024 | 1.12B | 10.88% |
May 13, 2024 | 1.01B | 4.52% |
May 10, 2024 | 968.80M | -1.96% |
May 9, 2024 | 988.20M | -2.41% |
May 8, 2024 | 1.01B | -0.85% |
May 7, 2024 | 1.02B | 7.77% |
May 6, 2024 | 947.70M | 1.20% |
May 3, 2024 | 936.50M | 7.90% |
May 2, 2024 | 867.90M | 15.97% |
May 1, 2024 | 748.40M | 4.09% |
Apr 30, 2024 | 719.00M | -2.26% |
Apr 29, 2024 | 735.60M | 3.55% |
Apr 26, 2024 | 710.40M | 2.39% |
Apr 25, 2024 | 693.80M | -4.07% |
Apr 24, 2024 | 723.20M | 0.70% |
Apr 23, 2024 | 718.20M | -1.41% |
Apr 22, 2024 | 728.50M | 1.96% |
Apr 19, 2024 | 714.50M | -2.20% |
Apr 18, 2024 | 730.60M | 2.14% |
Apr 17, 2024 | 715.30M | -7.44% |
Apr 16, 2024 | 772.80M | -6.27% |
Apr 15, 2024 | 824.50M | -5.40% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Mirum Pharmaceuticals | 1.16B |
Verona Pharma | 1.13B |
Scholar Rock Holding | 1.13B |
Cronos Group | 1.12B |
Cullinan Oncology | 1.12B |
Silence Therapeutics | 1.10B |
Collegium Pharmaceutical | 1.10B |
Cassava Sciences | 1.10B |